The U.S. Food and Drug Administration is reviewing two emergency use authorization requests for COVID-19 vaccines, with an outside advisory committee scheduled to meet next Thursday to review data from Pfizer and its German partner BioNTech. Dan digs in with former FDA commissioner Rob Califf, who talks about the EUA process, the science and who should make the final call. Plus, Axios media reporter Sara Fischer joins to discuss the future of theatrical releases.